Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308621 | 12530862 | 1 | I | 20160619 | 20160706 | 20160706 | PER | US-009507513-1606USA010368 | MERCK | 0.00 | Y | 0.00000 | 20160706 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308621 | 12530862 | 1 | PS | REBETOL | RIBAVIRIN | 1 | UNK | U | 20903 | CAPSULE | |||||||||
| 125308621 | 12530862 | 2 | SS | LEDIPASVIR | LEDIPASVIR | 1 | UNK | U | 0 | ||||||||||
| 125308621 | 12530862 | 3 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125308621 | 12530862 | 1 | Chronic hepatitis C |
| 125308621 | 12530862 | 2 | Chronic hepatitis C |
| 125308621 | 12530862 | 3 | Chronic hepatitis C |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125308621 | 12530862 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |